November 24, 2023
Our Pick of the Year; Major Catalysts and Valuation Drivers Ahead and a $4.60 Price Target
September 7, 2023
Targeting Multi-Billion Dollar Markets with Unmet Needs; Initiate with a Buy-Venture rating and a $6.00 price target
Our leadership consists of a passionate management team with diverse industry knowledge, committed to science, therapeutic drug discovery and development.
- Class A shares: 72
- Class B shares: 61,107,444
- Share options: 3,178129
- Warrants: 8,974,043
*Data current as of August 6, 2024
Healthcare
Drug Manufacturers
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical and Medicine Industry (3741)
Please send investor relations inquiries to the following email: